---
figid: PMC3809064__nihms488315f2
figtitle: Targeting Mutant Fibroblast Growth Factor Receptors in Cancer
organisms:
- NA
pmcid: PMC3809064
filename: nihms488315f2.jpg
figlink: /pmc/articles/PMC3809064/figure/F2/
number: F1
caption: Schematic diagram of signal transduction pathway activated by ligand-stimulated
  FGFRs.Ligand specificity is determined in part by an alternative splicing event
  in the C-terminal half of the third immunoglobulin domain (bright blue) in which
  either exon 8 or exon 9 can be used, producing the IIIb and IIIc isoforms, respectively.
  Ligand binding results in receptor autophosphorylation in the kinase domain region
  and phosphorylation of FRS2, which initiates a signaling cascade resulting in activation
  of the AKT and ERK downstream signaling pathways.
papertitle: Targeting Mutant Fibroblast Growth Factor Receptors in Cancer.
reftext: Heidi Greulich, et al. Trends Mol Med. ;17(5):10.1016/j.molmed.2011.01.012.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9601798
figid_alias: PMC3809064__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC3809064__F1
ndex: 91f8146f-dedb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3809064__nihms488315f2.html
  '@type': Dataset
  description: Schematic diagram of signal transduction pathway activated by ligand-stimulated
    FGFRs.Ligand specificity is determined in part by an alternative splicing event
    in the C-terminal half of the third immunoglobulin domain (bright blue) in which
    either exon 8 or exon 9 can be used, producing the IIIb and IIIc isoforms, respectively.
    Ligand binding results in receptor autophosphorylation in the kinase domain region
    and phosphorylation of FRS2, which initiates a signaling cascade resulting in
    activation of the AKT and ERK downstream signaling pathways.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VPREB1
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - IL1A
  - SOS1
  - KRAS
  - HRAS
  - NRAS
  - GRB2
  - FRS2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - GAB1
  - PIGU
  - PTPN11
  - CBL
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - PLCG1
  - PLCG2
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
